Introduction
Obesity is the result of complex molecular networks and an obesogenic environment which predispose to an inflammatory state. Evidence for infectobesity, a relatively new pathophysiological mechanism for obesity [1] , is supported by the phagocytic and microbicidal activity of the preadipocytes [2] and the association of disease with seasonality of birth (Winter -Spring), infections in early life [3, 4] , or exposure to some viral infections [5] .
Torque Teno virus (TTV or TT virus) has a small single-stranded circular DNA [6] . It is ubiquitously distributed in the body and biological products of infected subjects [7] . The disease-inducing potential of TTV is still questioned although active infection may increase the severity of some inflammatory diseases. There are no reports regarding association between human obesity and TTV in literature.
Interleukin 6 (IL6) is produced by adipose tissue among other cell types (e.g. hepatocyte, lymphocyte, endothelial cells). Genetic polymorphisms and plasma levels of IL6 have complex [8] and contradictory [9] relations with obesity [10] [11] [12] , BMI (Body Mass Index) [13] [14] [15] and inflammation [16] .
The renin angiotensin system (RAS) components have been detected in human preadipocytes [17] and in adipose tissue [18] . This system may be involved in inflammatory response [19] and obesity by different mechanisms [20] . Thus, it can influence expression of nuclear factor-kappa B (NF-kB) and IL6 genes and also adipocyte growth and differentiation [21] . Weight gain and obesity can predispose to upregulation of the AT1R [22] and activation of RAS in some tissues [23] . The aim of our study was to test the association between obesity, TTV infections and IL6 G-174C, ACE ID or AT1R A1166T polymorphisms.
Experimental Procedures

Subjects
Blood samples were collected from unrelated obese patients (n=150) and normal-weight controls (n=150) at three medical clinics in Bucharest (Romania). Patients had BMI of 30.10-39.99 kg/m 2 independent of gender. Subjects with indications of a monogenic form of obesity, neurological diseases, cancers or chronic viral infections were excluded from this study. Controls were selected from clinically healthy subjects with BMI: 20.01-24.99 kg/m 2 , blood pressure <120 mmHg and fasting glycemia <110 mg/dL. Patients and controls were matched for sex, age and Romanian ethnicity. All subjects were over the age of 18 years when recruited.
The hypertensive status (resting blood pressure exceeding 130/85 mm Hg or subject under antihypertensive treatment), the BMI (kg/m 2 ), smoking (more than five cigarettes per day for at least one year) and drinking (at least five units of alcohol per day for at least one year) habits were recorded for all participants.
This study was approved by the Nicolae Paulescu National Institute of Diabetes, Nutrition and Metabolic Diseases ethical committee and informed consent was obtained from all subjects.
Genotyping
Genomic DNA was isolated from peripheral blood (Wizard Genomic DNA Purification Kit, Promega) and quantified with Quant-iT™ PicoGreen ® (Invitrogen Corp., Carlsbad CA) in a Rotor-Gene 6000 (Corbett Research).
The IL6 G-174C (rs1800795) [24] , ACE I/D (rs4646994) [25] , AT1R A1166C (rs5186) [26] were genotyped according to protocols described previously with slight modifications/changes. The presence of ACE I variant was confirmed in a second PCR with a specific primer set for insertion [27] . TTV was detected in DNA samples using a heminested-PCR assay [28] . To reduce the likelihood of operator bias or methodological errors by the first set of analysis, DNA samples were blinded and independently analyzed.
Statistical analysis
The clinical data were presented as mean ±SD. Quantitative data were checked for normality of distribution with the Shapiro-Wilk W test and were compared with the Mann-Whitney test. The distribution of demographic characteristics, polymorphisms and frequency of TTV DNA in cases and controls were compared using the Chi-square or Fisher's Exact test, wherever appropriate. The Chi-square test was used to verify if the genotypes were distributed according to the Hardy Weinberg equilibrium. After stratification for sex and the presence of TTV infection, we performed a multivariate logistic regression with backward selection of covariates where we adjusted the presence of the C-174-C polymorphism for sex, smoking and drinking habits. The statistical analysis was performed with MedCalc Software, version 12.1.3.0 [29] . A P value <0.05 was considered to indicate a significant difference.
The study has between 58% and 73% power to detect a marker associated with disease when the odds ratio (OR) ranges between 1.5 and 2.0, respectively, and both disease prevalence and minor allele frequency are each higher than 0.25.
Results
The main characteristics of the investigated subjects are listed in Table 1 . Men were more frequent smokers, alcohol consumers and had significantly higher body weight (P<0.0009) compared with women from the same cohort. Obese men also presented higher triglycerides levels (P=0.01) and were more frequently hypertensive (P=0.03) than obese women. The distribution of ACE ID, AGTR1 A1166C and IL6 G-174C polymorphisms (Table 2 ) in investigated cohorts was not different from the Hardy-Weinberg equilibrium (P=0.06).
The CC genotype of the IL6 G-174C polymorphism was more common in the obese cohort ( and drinking habits, the CC genotype was associated with obesity when compared with the GG (P=0.03) genotype, independent of the other variables included in the model. In addition, when we included the presence of TTV infection in the model, the association remained significant (P=0.04). Also, when we analyzed the association of the CC genotype with obesity, compared with CG plus GG genotypes, the association was still present (P=0.04). However, when TTV infection was included in the model, infection was the only significant factor associated with obesity. Finally, when we analyzed the presence of one C allele, the association with obesity was not significant. No other significant differences within or between investigated lots and subgroups have been identified.
Discussion
In this case-control study we investigated the association between three common polymorphisms, infections with TTV and obesity. These polymorphisms have been associated with IL6 promoter activity, plasma levels of IL6 [30, 31] or ACE [25] and responsiveness of the AT1R [32] . There are several lines of experimental evidences which also support a potential link between TTV infection and inflammation or body weight: 1. transfection of TTV ORF2 into human cell lines could suppress NF-kB activity and transcription of different NF-kB-mediated downstream genes, including IL6 [33] ; 2. mice preadipocytes and adipocytes can express Toll-like receptors 9 which can modify IL6 production in response to specific stimuli [34] ; TTV DNA can activate Toll-like receptors 9 and can stimulate production and secretion of IL6 by immune cells [35] ; 3. some transgenic mice expressing TTV ORF1 [36] or high levels of circulating IL6 [37] present a reduced average body weight and low growth rate; primary infection with TTV can occur early in life [28] and abnormal body weight in early life was associated with risk for later diseases, including obesity [38] . The complex relationship between IL6, fat metabolism and obesity has been examined in many studies, yet the results are still conflicting. The serum IL6 levels are determined by particularities of adipose tissues, the strength of the promoter and the effects of different inducible factors. Adipose tissue has a significant contribution to IL6 levels (up to 35%) [39] [40] [41] and changes occurring in this tissue were directly correlated with levels of this cytokine [42] [43] [44] [45] . IL6 was also found to stimulate lipolysis in healthy humans [46] and in cultures of human adipocytes [47] or preadipocytes [48] and it is a powerful catabolic agent [49] with anti-obesity effects [50] in animals. Overall, IL-6 seems to limit energy deposition within adipose tissue.
The -174 C variant, alone or in combination with other neighboring markers [30] , has been related to lower levels of serum IL-6 [16, 51] . The -174CC genotype, which corresponds to a weaker promoter, was associated with obesity in some reports [11, 12] . This association is supported by the observations that IL6 deficient mice (Il6-/-) became obese [50] .
The IL6 promoter is highly inducible. The synthesis of this cytokine may be increased as a response to different stimuli, including viral infections. The promoter region -180 to -123, in which the polymorphism -174GC has been mapped, contains important cis-acting regulatory elements responsible for viruses induced gene transcription [52, 53] . Knock-out mice for this gene have an impaired response to certain viral infections [54, 55] . This evidence is in line with our results, which showed an association of the CC genotype with obesity, possibly via decreased IL-6 levels.
In this study the TTV genome was more frequently detected in obese women than in controls of the same gender (P=0.046, OR=1.87). The TTV was similarly distributed in subgroups of subjects selected according to hypertension, smoking or drinking habits. When subjects without TTV infections were analyzed, only the IL6 -174 CC genotype was more frequent in the obese than in the control subgroup (P=0.03).
It is difficult to explain the preferential distribution of TTV in obese women based on available data. It has been previously reported that TTV has a high genetic diversity, multiple routes of transmission. The virus is common in general populations where it produces chronic infections. The percentage of infected subjects seems to be unrelated to gender [56] [57] [58] [59] . The blood transfusion route cannot explain our results as none of the selected subjects had received blood transfusions or surgical interventions. The IL6 -176 CC genotype was also found to be more common in obese subjects (P=0.02) than in controls. Either this genotype or a haplotype which includes IL6 G-174C were associated with obesity markers in some [11, 12] , but not all, studies [9] .
We found that distribution of ACE ID and ATR1 A1166C polymorphisms present no significant differences in patients and control lots (P>0.05) regardless of gender, age or BMI. Similarly, these polymorphisms were not associated with indexes of obesity in the Chinese population [60] , Korean [61] and Iranian females [62] or Romanian T2DM patients [63] . In contrast with these data, the ACE ID variants [64] [65] [66] and the AT1R CC genotype [67] were associated with markers of obesity in other studies.
Carriers of the AT1R C allele, including obese men and women, and healthy men (P=0.04, P=0.03 and P<0.014 respectively), exhibited higher triglyceride levels compared to non-carriers from the same group. Although the analyses were performed for each gender separately, ACE ID, IL6 G-174C and presence of TTV infections were not associated with significant difference of triglycerides or cholesterol levels.
A high prevalence (70.67%) of TTV was detected in our controls. TTV is common in blood donors [68] and a high percentage of the general population exhibits chronic viraemia (around 80% in some areas) [69] . In the control group the minor alleles frequencies of IL6 G-174C (-174 C: 0.2133) [70] , ACE ID (I: 0.4767) [71] and ATR1 A1166C (1166 C: 0.2967) [62, 72] were in the range of data reported for other worldwide populations.
In conclusion, our data demonstrate that common form of obesity can be associated with the homozygous IL6 CC genotype or with TTV infections in women.
